Responding to COVID-19 and biologic demands, DuPont adds capacity at silicone business Liveonews2021-09-09T13:15:28+00:00September 9th, 2021|Fierce Pharma|
WCLC: AstraZeneca’s detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut winnews2021-09-09T12:07:21+00:00September 9th, 2021|Fierce Pharma|
Genome of South Korea gains CDMO capability and drug material insurance with $27M purchase of List Labsnews2021-09-09T03:50:46+00:00September 9th, 2021|Fierce Pharma|
Sanofi, Regeneron’s Dupixent tops TV spending again, with AbbVie’s Rinvoq close behindnews2021-09-08T20:47:31+00:00September 8th, 2021|Fierce Pharma|
No joy for Ajovy: Teva’s migraine drug can’t find a win in meta-analysis versus Biohaven, AbbVie medsnews2021-09-08T19:30:57+00:00September 8th, 2021|Fierce Pharma|
No joy for Ajovy: Teva’s migraine drug can’t find a convincing win in meta-analysis versus Biohaven, AbbVie medsnews2021-09-08T19:30:57+00:00September 8th, 2021|Fierce Pharma|
As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequencesnews2021-09-08T15:26:33+00:00September 8th, 2021|Fierce Pharma|
GSK, Pfizer and Johnson & Johnson race toward $10B+ RSV vaccine market: analystnews2021-09-08T14:39:22+00:00September 8th, 2021|Fierce Pharma|
GSK, Pfizer and Johnson & Johnson race toward $10B-plus RSV vaccine market: analystnews2021-09-08T14:39:22+00:00September 8th, 2021|Fierce Pharma|
Moderna taps National Resilience’s new Canadian manufacturing site for COVID-19 vaccine production dutiesnews2021-09-08T13:49:15+00:00September 8th, 2021|Fierce Pharma|
